Macrolactam calcineurin inhibitor (similar to tacrolimus) that binds macrophilin-12 (FKBP-12-like protein), blocking calcineurin and inhibiting T-cell activation and cytokine production. Used for immune-mediated ocular surface disease.
At a glance
Class
Ophthalmic Calcineurin Inhibitor / Immunomodulator
Storage
Per compounding pharmacy instructions; typically room temperature
Dosing
Used for immune-mediated KCS, pannus (chronic superficial keratitis), and pigmen
Used for eosinophilic keratitis and immune-mediated conjunctivitis refractory to
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet.
Find a vet near you →Safety
Schirmer tear testCorneal clarityClinical response at 4–8 weeks
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet.
Find a vet near you →Interactions
No documented interactions.
Brands
Other markets
Pimecrolimus Ophthalmic (compounded)
FAQs
Frequently asked questions
›What is Pimecrolimus Ophthalmic?
Pimecrolimus Ophthalmic is a ophthalmic calcineurin inhibitor / immunomodulator used in pets. Macrolactam calcineurin inhibitor (similar to tacrolimus) that binds macrophilin-12 (FKBP-12-like protein), blocking calcineurin and inhibiting T-cell activation and cytokine production. Used for immune-mediated ocular surface disease.
›What is Pimecrolimus Ophthalmic used for in pets?
Pimecrolimus Ophthalmic is used in veterinary medicine for: Used for immune-mediated KCS, pannus (chronic superficial keratitis), and pigmen; Used for eosinophilic keratitis and immune-mediated conjunctivitis refractory to.
›What is the Pimecrolimus Ophthalmic dose for dogs?
For dogs, Pimecrolimus Ophthalmic is typically dosed as follows — Used for immune-mediated KCS, pannus (chronic superficial keratitis), and pigmen: undefined undefined Ophthalmic q12h. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
›What is the Pimecrolimus Ophthalmic dose for cats?
For cats, Pimecrolimus Ophthalmic is typically dosed as follows — Used for eosinophilic keratitis and immune-mediated conjunctivitis refractory to: undefined undefined Ophthalmic q12h. Always consult your veterinarian for a dose tailored to your pet's weight, age, and condition.
›Does Pimecrolimus Ophthalmic need a prescription?
Yes. Pimecrolimus Ophthalmic is a prescription medication and should only be administered under veterinary supervision.
Educational reference only
This information is provided for educational purposes and is not a substitute for professional veterinary advice, diagnosis, or treatment. Always consult a qualified veterinarian before administering any medication to your pet.
Find a vet near you →References
References
The PetCare.AI drug reference is built from 13 authoritative sources cited across 580 drug monographs.
Textbooks & handbooks — 5
- Plumb's Veterinary Drug Handbook
- Withrow & MacEwen's Small Animal Clinical Oncology
- Merck Veterinary Manual
- NRC Nutrient Requirements of Dogs and Cats
- Veterinary Pharmacology and Therapeutics (Riviere & Papich)
Clinical guidelines & consensus — 4
- ASPCA Animal Poison Control Center Guidelines
- AAHA Diabetes Management Guidelines
- ASPCA Poison Control Guidelines
- RECOVER CPR Guidelines
Journals & peer-reviewed studies — 2
- EPIC Study (J Vet Intern Med 2016)
- JVIM FAT CAT Study
Regulatory & approvals — 1
- CDSCO Veterinary Drug Approval Registry (1969–2026)
Databases — 1
- Washington State University VCPL MDR1 Database